68 jili
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its Advances in Oncology – 2024 Research Highlights , underscoring major strides in cancer research and ongoing innovation. However, the optimism is tempered by a troubling finding: a significant global rise in early-onset colorectal cancer cases . This unsettling trend comes as the medical community grapples with the lingering effects of the COVID-19 pandemic. A recent Nature article revealed how disruptions in cancer care—particularly delays in screenings, diagnoses, and treatments—have likely exacerbated the progression of advanced disease, diminished survival rates, and complicated long-term data analysis. Still, the oncology field continues to push forward with promising developments emerging from key innovators like O ncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Cardiff Oncology, Inc. (NASDAQ: CRDF), Personalis, Inc. (NASDAQ: PSNL), Tempus AI, Inc. (NASDAQ: TEM), and Checkpoint Therapeutics, Inc. (NASDAQ: CKPT). The article continued: Additionally, the American Cancer Society has spotlighted an alarming rise in cancer incidence and mortality among younger age groups. Analysts at Exactitude Consultancy anticipate that the global Cancer Immunotherapy Market will expand at a robust 12.84% CAGR, reaching $258.22 billion by 2031 —a clear indicator of oncology's rapid growth and critical importance. Oncolytics Biotech® to Present Promising Pelareorep Data in Pancreatic and Anal Cancers at ASCO GI Symposium Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the presentation of two data sets through two abstracts showcasing pelareorep's potential in difficult-to-treat gastrointestinal cancers, which were accepted and will be presented at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco January 23-25, 2025 . "We are enthusiastic about pelareorep's applicability across multiple gastrointestinal cancer indications, including pancreatic and anal cancer," said Tom Heineman , M.D., Ph.D., Chief Medical Officer of Oncolytics . "Pelareorep engages patients' immune systems to help make commonly used chemotherapies and checkpoint inhibitors, such as atezolizumab, more effective in fighting cancer. This offers the promise of delaying disease progression and improving survival in patients with these devasting diseases. Given the versatility of pelareorep, we see multiple clinical and regulatory options for bringing this promising medicine to patients." Oncolytics will present two key data sets from the GOBLET study, with preliminary safety and tumor response results for the relapsed anal carcinoma cohort treated with pelareorep and atezolizumab presented in Poster Session C on January 25, 2025 , from 7:00 to 7:55 a.m. PT . Additionally, results from the safety run-in phase for first-line metastatic pancreatic ductal adenocarcinoma patients treated with pelareorep, modified FOLFIRINOX, with and without atezolizumab will be presented in Poster Session B on January 24, 2025 , from 11:30 a.m. to 1:00 p.m. PT . Both abstracts will be available on the ASCO Gastrointestinal Cancers Symposium website at 5:00 p.m. ET on January 21, 2025 . CONTINUED... Read this and more news for Oncolytics Biotech at: https://usanewsgroup.com/2023/10/02/the-most-undervalued-oncolytics-company-on-the-nasdaq/ In other recent industry developments and happenings in the market include: Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently announced positive initial data from CRDF-004, a randomized, Phase 2 clinical trial evaluating onvansertib in combination with standard-of-care (SoC) in patients with first-line RAS-mutated metastatic colorectal cancer (mCRC). Efficacy and safety data are for all evaluable patients as of a November 26, 2024 , data cut-off date, and all efficacy data are determined by a blinded, independent central review (BICR) of each patient's tumor scan. "We are highly encouraged by the robust efficacy signal and favorable safety profile observed with onvansertib plus standard-of-care from the first 30 evaluable patients in our randomized first-line RAS-mutated mCRC CRDF-004 trial," said Fairooz Kabbinavar, MD, FACP, Chief Medical Officer of Cardiff Oncology . "Our data shows an objective response rate of 64% in patients receiving the 30 mg dose of onvansertib in combination with standard of care, significantly higher than the 33% objective response rate observed in the control arms of standard of care alone. In addition, as can be seen in the spider plots, we are observing deeper tumor response in patients receiving the 30mg dose of onvansertib compared to those receiving the 20mg dose with similar safety profiles for both doses." Personalis, Inc. (NASDAQ: PSNL), a developer of advanced cancer genomic tests and analytics, and Tempus AI, Inc. (NASDAQ: TEM), an AI-powered healthcare technology company, recently announced they've expanded their commercial relationship. Both companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Tempus is serving as the exclusive commercial diagnostic partner for Personalis' ultra-sensitive tumor-informed MRD product, NeXT Personal® Dx, for broad patient adoption in breast and lung cancers, and for immunotherapy monitoring across all solid tumors. "While we already offer NeXT Personal through our own biopharma channel, we are pleased to leverage Tempus' integrated platform as well for these biopharma customers who desire to combine NeXT Personal with other Tempus products," said Chris Hall , CEO of Personalis . "We believe the expansion of the relationship with Tempus will accelerate market penetration of our leading ultra-sensitive MRD platform and allow us to better capitalize on the opportunity." Under this expanded relationship, Tempus will be enabled to offer Personalis' NeXT Personal MRD product to pharmaceutical and biotech customers who wish to bundle MRD testing with other Tempus offerings in a given study. Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a commercial-stage immunotherapy and targeted oncology company focused on novel treatments for patients with solid tumor cancers, recently announced that the FDA approved its UNLOXCYTTM (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT is the first and only programmed death ligand-1 (PD-L1) blocking antibody to receive FDA marketing approval for this indication. "[This] FDA approval of UNLOXCYT – the first marketing approval for our company – is a significant milestone both for Checkpoint and for patients with advanced cSCC," said James Oliviero , President and CEO of Checkpoin t. "This approval marks Checkpoint's transformation to a commercial-stage company, with the opportunity to compete in a U.S. market estimated to exceed $1 billion annually, where we believe UNLOXCYT offers a differentiated treatment option versus available therapies by binding to PD-L1, rather than programmed death receptor-1 (PD-1), to release the inhibitory effects of PD-L1 on the anti-tumor immune response. Additionally, UNLOXCYT has demonstrated the ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC), another potential differentiating feature of the drug compared to existing marketed therapies for patients with cSCC." Source: https://usanewsgroup.com/2024/09/21/is-oncolytics-biotech-the-markets-most-undervalued-cancer-opportunity/ CONTACT: USA NEWS GROUP info@usanewsgroup.com (604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Oncolytics Biotech Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares of Oncolytics Biotech Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Oncolytics Biotech Inc. which were purchased in the open market, and reserve the right to buy and sell, and will buy and sell shares of Oncolytics Biotech Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Oncolytics Biotech Inc.; this is a paid advertisement, we currently own shares of Oncolytics Biotech Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. View original content: https://www.prnewswire.com/news-releases/oncology-advancements-accelerate-amid-rising-early-onset-cancer-diagnoses-302337555.html SOURCE USA News Group
The midseason four-game winning streak that lifted the Arizona Cardinals into the playoff picture seemed as though it happened fast. Their subsequent free fall has been even more jarring. The Cardinals could have moved into a tie for first place in the NFC West with a home win over the Seattle Seahawks on Sunday. Instead, they were thoroughly outplayed in a 30-18 loss and are now tied for last in the tightly packed division. Arizona has lost three straight and will face an uphill battle to return to the playoffs for the first time since 2021. The Seahawks (8-5) are in first place, followed by the Rams (7-6), Cardinals (6-7) and 49ers (6-7). Even more daunting for their playoff hopes, the Cardinals lost both of their games against the Seahawks this season, meaning a tiebreaker would go to Seattle. Four games remain. “I just told them we put ourselves in a little bit of a hole now, but all you can do is attack tomorrow, learn tomorrow and have a good week of practice,” second-year coach Jonathan Gannon said. There are plenty of reasons the Cardinals lost to the Seahawks, including Kyler Murray's two interceptions, a handful of holding penalties, a porous run defense and a brutal missed field goal. It all adds up to the fact Arizona is playing its worst football of the season at a time when it needed its best. “I’m sure we’ll stick to our process, but we have to tweak some things,” Gannon said. "I have to tweak some things.” It's probably faint praise, but the Cardinals did make the game interesting in the second half while trying to fight back from a 27-10 deficit. Murray's shovel pass to James Conner for a 2-yard touchdown and subsequent 2-point conversion cut the margin to 27-18. The Cardinals had a chance to make it a one-score contest early in the fourth quarter, but Chad Ryland's 40-yard field goal attempt bounced off the left upright. “I thought we spotted them a lot of points there, but then we battled back,” Gannon said. “I appreciate their effort. That was good. We battled back there, had a couple chances to even cut the lead a little more, but ultimately didn’t get it done." Murray's in a bit of a mini-slump after throwing two interceptions in back-to-back games for the first time in his career. He also didn't do much in the run game against the Seahawks, with 16 yards on three carries. The quarterback's decision-making was nearly flawless for much of the season and the Cardinals need that good judgment to return. “I’m not looking at it like I have to try to be Superman,” Murray said. “I don’t think that’s the answer. I just need to play within the offense like we’ve done for the majority of the season. Today, I didn’t. Like I said, throwing two picks puts yourself behind the eight ball.” Said Gannon: “I thought he stuck in there and made some big time throws, though, but he has to protect the ball a little bit better. That’s not just him, that’s all 11. So there’ll be a lot of corrections off those plays." The defense didn't have its best day, but it's not Budda Baker's fault. The two-time All-Pro safety is having another phenomenal season and was all over the field against the Seahawks, finishing with 18 tackles. Baker's energy is relentless and he's the unquestioned leader of a group that has been better than expected this season, even with Sunday's mediocre performance. Left tackle Paris Johnson Jr. had a tough day, getting flagged for holding three times, though one of those penalties was declined by the Seahawks. The second-year player moved from right tackle to the left side during the offseason and the transition has gone well, but Sunday was a step backward. The Cardinals remain fairly healthy. DL Roy Lopez (ankle) and P Blake Gillikin (ankle) left Sunday's game, but neither injury is expected to be long term. 9 — It looks as if the Cardinals will go a ninth straight season without winning the NFC West. The last time they won the division was 2015 with coach Bruce Arians and a core offense of quarterback Carson Palmer, running back David Johnson and receiver Larry Fitzgerald. The Cardinals are in must-win territory now for any chance at the playoffs. They'll host the New England Patriots on Sunday. AP NFL: https://apnews.com/hub/NFL
EL PASO, Texas (AP) — Ahamad Bynum scored 19 points off of the bench to help lead UTEP over Seattle U 88-72 on Saturday night. Bynum shot 7 of 9 from the field and 3 of 3 from the free-throw line for the Miners (6-2). Otis Frazier III added 18 points while going 6 of 9 from the floor, including 2 for 3 from 3-point range, and 4 for 4 from the line while he also had five assists. Kevin Kalu had 13 points and shot 5 of 6 from the field and 3 for 3 from the line. The Redhawks (3-6) were led in scoring by Paris Dawson, who finished with 18 points and two steals. Seattle U also got 14 points and eight rebounds from Matthew-Alexander Moncrieffe. John Christofilis had 13 points. UTEP took the lead with 18:55 left in the first half and never looked back. The score was 48-23 at halftime, with Frazier racking up 12 points. UTEP extended its lead to 77-49 during the second half, fueled by a 7-0 scoring run. Bynum scored a team-high 12 points in the second half as their team closed out the win. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
Business wins, strategic collaborations, and renewed commitment to client partnership highlight a year of transformation PITTSBURGH , Dec. 20, 2024 /PRNewswire/ -- Net Health , a trusted source for specialized software solutions that empower restorative care providers across the continuum of care, is entering 2025 with impressive momentum driven by a year of transformative leadership. Through rebranding initiatives, partnerships and collaborations, and award recognitions, the company has redefined its organizational vision, advanced its mission to deliver impactful healthcare solutions, and solidified its position as a leader in the healthcare technology space. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Rico Carty, who won the 1970 NL batting title with the Atlanta Braves, dies at 85Paramount Global Announces Redemption of its 4.750% Senior Notes due May 2025
Banking Stocks Drop Amid Martial Law: 11 Trillion Won Lost
Cardinals' sudden 3-game tailspin has turned their once solid playoff hopes into a long shotHURST, Texas, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Toll Brothers at Adkins Park , is coming soon to Hurst, Texas. This new community will include a refined collection of single-family homes located at Precinct Line Road and Doppler Court in Hurst. Site work is underway, and the community is anticipated to open for sale in early 2025. Showcasing one- and two-story single-family homes on expansive 70-foot home sites, Toll Brothers at Adkins Park offers spacious, open-concept floor plans ranging from 3,089 to over 4,940+ square feet with 4 to 6 bedrooms, modern architecture, and outstanding options for personalization at the Toll Brothers Design Studio. Anticipated pricing starts in the $1,000,000s. “Our new Toll Brothers at Adkins Park community will offer residents the rare opportunity to build a new construction home within the well-established Hurst area and the highly desirable Keller Independent School District,” said Jay Saunders, Division President of Toll Brothers in Dallas-Fort Worth. “Surrounded by every convenience including local shopping and dining, top schools, and popular recreation opportunities, Toll Brothers at Adkins Park will epitomize luxury living.” Homeowners in the community will enjoy easy access to the nearby Cotton Belt Trail offering 13 miles of hiking and biking. The community is located just 20 minutes from Dallas Fort Worth International Airport, making it convenient for frequent travelers. Children in the community will have the opportunity to attend schools in the highly acclaimed Keller Independent School District, including Liberty Elementary, Keller Middle School, and Keller High School. Home buyers will experience one-stop shopping at the Toll Brothers Design Studio . The state-of-the-art Design Studio allows home buyers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants. For more information and to join the Toll Brothers interest list for Toll Brothers at Adkins Park, call (855) 289-8656 or visit TollBrothers.com/DFW . About Toll Brothers Toll Brothers, Inc., a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded 57 years ago in 1967 and became a public company in 1986. Its common stock is listed on the New York Stock Exchange under the symbol “TOL.” The Company serves first-time, move-up, empty-nester, active-adult, and second-home buyers, as well as urban and suburban renters. Toll Brothers builds in over 60 markets in 24 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Indiana, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, and Washington, as well as in the District of Columbia. The Company operates its own architectural, engineering, mortgage, title, land development, smart home technology, and landscape subsidiaries. The Company also develops master-planned and golf course communities as well as operates its own lumber distribution, house component assembly, and manufacturing operations. In 2024, Toll Brothers marked 10 years in a row being named to the Fortune World’s Most Admired CompaniesTM list and the Company’s Chairman and CEO Douglas C. Yearley, Jr. was named one of 25 Top CEOs by Barron’s magazine. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com . From Fortune, ©2024 Fortune Media IP Limited. All rights reserved. Used under license. ### Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | ameck@tollbrothers.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d067a325-806f-4db6-af40-5ef6930a48c6 Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)
Willy Adames agrees to $182 million, 7-year deal with the Giants, AP source says Willy Adames has agreed to a $182 million, seven-year deal with San Francisco, providing the Giants with a power-hitting shortstop in the prime of his career, according to a person familiar with the negotiations. The person spoke to The Associated Press on condition of anonymity because the agreement was pending a physical. ESPN first reported the move. The 29-year-old Adames is coming off his best offensive season in the big leagues after hitting .251 with a career-high 32 homers and 112 RBIs with the Milwaukee Brewers. Georgia QB Carson Beck knocked out by hand injury in SEC championship game against Texas ATLANTA (AP) — Georgia quarterback Carson Beck will not return after he was hit on his throwing hand on the final play of an ugly first half in the Southeastern Conference championship game against Texas. Beck was hit by outside linebacker Trey Moore, forcing a fumble recovered by Anthony Hill Jr., who then lost the ball on an errant attempt to extend the play with a lateral as time expired. Beck was one of the last players to return to the field following halftime. Backup Gunner Stockton led the offense to a touchdown on the Bulldogs’ first drive of the second half. Arizona State makes College Football Playoff with 45-19 win over Iowa State in Big 12 title game ARLINGTON, Texas (AP) — Big 12 newcomer Arizona State will represent the conference in the 12-team College Football Playoff. Cam Skattebo ran for 170 yards and two scores while adding a touchdown catch the 12th-ranked Sun Devils beat No. 16 Iowa State 45-19 in the Big 12 championship game. The Sun Devils with 34-year-old head coach Kenny Dillingham are 11-2 after being the preseason pick to finish at the bottom of their new 16-team league. They have won six games in a row. Iowa State is 10-3, already the first 10-win season in the program's 133-year history. LA Galaxy strike early, hold off New York Red Bulls 2-1 to win their record 6th MLS Cup championship CARSON, Calif. (AP) — Joseph Paintsil and Dejan Joveljic scored in the first half, and the LA Galaxy won their record sixth MLS Cup championship with a 2-1 victory over the New York Red Bulls. After striking twice in the first 13 minutes with goals from their star forwards, the Galaxy nursed a lead through a scoreless second half to raise their league’s biggest trophy for the first time since 2014. Sean Nealis scored for the seventh-seeded Red Bulls, whose improbable charge through the playoffs ended one win shy of the founding MLS franchise’s first Cup championship. No. 16 Iowa State falls short in Big 12 title game again, this time with CFP at stake ARLINGTON, Texas (AP) — The stakes were higher for Iowa State, and the outcome was the same as the first for the Cyclones in their second trip to the Big 12 championship game. And the 112-year wait for a conference title will go on. No. 16 Iowa State was playing for a spot in the expanded 12-team College Football Playoff in a 45-19 loss to 12th-ranked Arizona State. Four years ago, neither Iowa State nor Oklahoma had a realistic path into the four-team tournament before the Sooners' 27-21 victory. The Cyclones haven't won a conference title since going 2-0 in the Missouri Valley Intercollegiate Athletic Association in 1912. Big 12's Yormark brings up hard choices for fans before sparsely attended title game ARLINGTON, Texas (AP) — College football fans are facing some hard choices in the expanded playoff system with some teams set to play away from home multiple times. Big 12 Commissioner Brett Yormark raised that point No. 12 Arizona State's 45-19 victory over 16th-ranked Iowa State. The announced crowd of 55,889 at the home of the Dallas Cowboys appeared far smaller. Yormark says he remains committed to having a Big 12 title game. Besides the issues of fans, there have been suggestions that some leagues might be better off without title games as it relates to playoff hopes. Lindsey Vonn competes in a pair of downhills, another step on her comeback trail at the age of 40 COPPER MOUNTAIN, Colo. (AP) — Lindsey Vonn finished in the middle of the pack in a pair of lower-level downhill events as she competed for the first time in nearly six years. The 40-year-old Vonn is on the comeback trail after stepping away from the sport because of injuries. Vonn wasn't concerned with times and places in the races so much as getting used to the speed again and gaining the necessary points to compete on the World Cup circuit. Vonn accomplished both, finishing 24th in the first downhill race of the day and 27th in the second. She posted on social media after the FIS races she had enough points to enter World Cup events. Justin Thomas with big drives and a few big putts takes 1-shot lead over Scheffler in the Bahamas NASSAU, Bahamas (AP) — Justin Thomas has a one-shot lead over Scottie Scheffler going into the final round of the Hero World Challenge in the Bahamas. Thomas is using a slightly longer driver and has been blasting away. He also was helped by two long putts on the back nine that carried him to 66 at windy Albany Golf Club. Scheffler muffed a chip on the 13th hole that cost him the lead and he never caught up. He still shot a 69 and will be in the last group with Thomas on Sunday. Tom Kim had a 62 and was two shots back. Oklahoma State coach Mike Gundy gets restructured deal after 3-9 season, according to reports Oklahoma State football coach Mike Gundy will be staying on with a restructured deal. That's according to news reports published on Saturday. The deal reportedly will shift some of his salary to revenue sharing with players. The Cowboys were among the preseason favorites in the Big 12, but a rash of injuries and problems at quarterback tanked the team, and the Cowboys went 3-9. The school's Board of Regents held a special meeting on Friday morning regarding his status, but no immediate action was taken. The fact that Gundy has 169 wins in 20 years plus a hefty buyout likely saved him from being fired outright. Norris takes pole for season-ending Abu Dhabi GP and Hamilton 18th in Mercedes farewell ABU DHABI, United Arab Emirates (AP) — Lando Norris took pole position for the last Formula 1 race of the season alongside teammate Oscar Piastri to put McLaren on the verge of a first constructors’ title in 26 years. Norris’ last lap put him .209 of a second faster than Piastri, with Ferrari’s Carlos Sainz Jr. .020 further back. Seven-time F1 champion Hamilton qualified 18th for his last race with Mercedes after a bizarre incident wrecked his final qualifying lap. A plastic pole marking the inside of a corner was knocked loose by Kevin Magnussen’s Haas and Hamilton drove over it.NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Southwest Airlines Co. (NYSE: LUV) in connection with Southwest Airlines' information technology infrastructure impacting the Company's business, operations, and stock price. If you currently own shares of Southwest Airlines stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=10716 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com . Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40 th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-southwest-airlines-co--luv-302334153.html SOURCE THE ROSEN LAW FIRM, P. A.
Not many people have heard of before, but it is based out of New York and recognizes technology that prioritizes customer well-being by reducing their stress and cognitive load. Remarkable is the first e-paper device to become certified. This is due to the device not having any distractions, such as a web browser, social media or popups. To be awarded certification by the Calm Tech Institute, a product is evaluated against an 84-point standard based on Calm Technology principles. Examples include the product’s demands on a user’s attention, the periphery, robustness, light, sound, and material use. reMarkable Paper Pro joins a select group of early products and is awarded certification. These products share the common trait of creating experiences that work with our attention, not against it. reMarkable has been in the business of calm technology since the launch of our original paper tablet in 2017,” said Jon Dalvang, vice president of product design at reMarkable. “With reMarkable Paper Pro, we’re pushing boundaries in the market for better thinking tools. We’re honoured to receive this pioneering ‘Calm Tech’ certification, which inspires us to continue developing products that put human focus and deep thinking at the center.” Launched in September 2024, reMarkable Paper Pro is a digital notebook combining the freeing simplicity of writing on paper with powerful tools for editing and sharing your work. It is also the first remarkable product with a colour E INK screen, which adds versatility. Michael Kozlowski is the editor-in-chief at Good e-Reader and has written about audiobooks and e-readers for the past fifteen years. Newspapers and websites such as the CBC, CNET, Engadget, Huffington Post and the New York Times have picked up his articles. He Lives in Vancouver, British Columbia, Canada.
ATLANTIC CITY, N.J. (AP) — It doesn't happen all that often, but when it does, it can seem like a dream come true for sports gamblers: being able to bet on a game after it has already ended. And it has happened again in Atlantic City, where a sportsbook has been fined for taking $25,000 worth of bets on college basketball and hockey games and boxing matches after they were over. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.Elon Musk's budget crusade could cause a constitutional clash in Trump's second termRico Carty, who won the 1970 NL batting title with the Atlanta Braves, dies at 85
Rico Carty, who won the 1970 NL batting title when he hit a major league-best .366 for the Atlanta Braves, has died. He was 85. Major League Baseball , the players’ association and the Braves paid tribute to Carty on social media on Sunday. A family friend told Listín Diario — a newspaper in Carty’s native Dominican Republic — that he died Saturday night in an Atlanta hospital.
Best TV of 2024: A modestly better lineup than usual, but why didn’t it feel that way?MANILA, Philippines — President Ferdinand Marcos Jr. on Friday assured the Armed Forces of the Philippines (AFP) of his administration's continued support to make the country's military at par with the world's finest armed forces. In a speech during the 89th anniversary celebration of the AFP in Quezon City, Marcos said his administration was committed to ensuring that the AFP was prepared for a future which "demands that we meet these evolving challenges head-on." "Through the Self-Reliant Defense Posture Revitalization Program, we aim to reduce our dependence on foreign sources and empower the AFP to develop its own capabilities," Marcos said. Register to read this story and more for free . Signing up for an account helps us improve your browsing experience. OR See our subscription options.
COLUMBUS, Ohio -- Amazon Web Services will invest another $10 billion to bolster its data center infrastructure in Ohio. The company and Republican Gov. Mike DeWine announced the plan Monday. The new investment will boost the amount it has committed to spending in Ohio by the end of 2029 to more than $23 billion. AWS launched its first data centers in the state in 2016 and currently operates campuses in two counties in central Ohio, home to the capital city of Columbus. The new investment will allow AWS to expand its data centers to new sites, but the company said those locations have not been determined yet and noted that its investment plans are contingent upon the execution of long-term energy service agreements. AWS said the new data centers will contain computer servers, storage drives, networking equipment and other forms of technology infrastructure used to power cloud computing, including artificial intelligence and machine learning. In June 2023, AWS said it would invest $7.8 billion by the end of 2029 to expand its data center operations in central Ohio. That was on top of $6 billion already invested through 2022.